Mining the gastric cancer secretome: Identification of GRN as a potential diagnostic marker for early gastric cancer

Journal of Proteome Research

Volumn 11, Issue 3, 2012, Pages 1759-1772

  Loei, Hendrick ^a   Tan, Hwee Tong ^a   Lim, Teck Kwang ^b   Lim, Kiat Hon ^c   So, Jimmy Bok Yan ^a   Yeoh, Khay Guan ^d   Chung, Maxey C M ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

biomarker; gastric cancer; granulin; GRN; iTRAQ; proteomics; secretome

Indexed keywords

BIOLOGICAL MARKER; PROTEOME; SECRETOME; UNCLASSIFIED DRUG;

ADULT; CELL DIFFERENTIATION; CELL LYSATE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; STOMACH CANCER;

ADENOCARCINOMA; AGED; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROTEOME; ROC CURVE; SECRETORY PATHWAY; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84857816893     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr201014h     Document Type: Conference Paper

References (36)

1. Garcia, M.; Jemal, A.; Ward, E. M.; Center, M. M.; Hao, Y.; Siegel, R. L.; Thun, M. J. Global Cancer Facts & Figures; American Cancer Society: Atlanta, GA, 2007.
2. Trends In Cancer Incidence In Singapore 2004-2008; Singapore Cancer Registry, Interim Report; National Registry of Diseases Office.: 2010.
3. Moriguchi, S.; Maehara, Y.; Korenaga, D.; Sugimachi, K.; Nose, Y. Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer Surg. Oncol. 1992, 1, 341-346
4. Roviello, F.; Marrelli, D.; de Manzoni, G.; Morgagni, P.; Di Leo, A.; Saragoni, L.; De Stefano, A. Prospective study of peritoneal recurrence after curative surgery for gastric cancer Br. J. Surg. 2003, 90, 1113-1119
5. Liotta, L. A.; Kohn, E. C. The microenvironment of the tumor-host interface Nature 2001, 411, 375-379
6. Tjalsma, H.; Bolhuis, A.; Jongbloed, J. D.; Bron, S.; Dijl, J. M. Signal peptide-dependent protein transport in Baciluus subtilis: a genome-based survey of the secretome Microbiol. Mol. Biol. Rev. 2000, 64, 515-547
7. Chen, Y.; Zhang, H.; Xu, A.; Li, N.; Liu, J.; Liu, C.; Lv, D.; Wu, S.; Huang, L.; Yang, S.; He, D.; Xiao, X. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer Lung Cancer 2006, 54, 95-102
8. Lou, X.; Xiao, T.; Zhao, K.; Wang, H.; Zheng, H.; Lin, D.; Lu, Y.; Gao, Y.; Cheng, S.; Liu, S.; Xu, N. Cathepsin D is secreted from M-BE cells: its potential role as a biomarker of lung cancer J. Proteome Res. 2007, 6, 1083-1092
9. Kim, J. E.; Koo, K. H.; Kim, Y. H.; Sohn, J.; Park, Y. G. Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model Exp. Mol. Med. 2008, 40, 709-720
10. Wang, C. L.; Wang, C. I.; Liao, P. C.; Chen, C. D.; Liang, Y.; Chuang, W. Y.; Tsai, Y. H.; Chen, H. C.; Chang, Y. S.; Yu, J. S.; Wu, C. C.; Yu, C. J. Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome J. Proteome Res. 2009, 8, 4428-4440
11. Planque, C.; Kulasingan, V.; Smith, C. R.; Reckamp, K.; Goodglick, L.; Diamandis, E. P. Identification of five candidate lung cancer biomarkers by proteomic analysis of conditioned media of four lung cancer cell lines Mol. Cell. Proteomics 2009, 12, 2746-58
12. Grønborg, M.; Kristiansen, T. Z.; Iwahori, A.; Chang, R.; Reddy, R.; Sato, N.; Molina, H.; Jensen, O. N.; Hruban, R. H.; Goggins, M. G.; Maitra, A.; Pandey, A. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach Mol. Cell. Proteomics 2006, 5, 157-171
13. Wu, C. C.; Chien, K. Y.; Tsang, N. M.; Chang, K. P.; Hao, S. P.; Tsao, C. H.; Chang, Y. S.; Yu, J. S. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model Proteomics 2005, 5, 3173-3182
14. Sardana, G.; Jung, K.; Stephan, C.; Diamandis, E. P. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers J. Proteome Res. 2008, 7, 3329-3338
15. Mbeunkui, F.; Metge, B. J.; Shevde, L. A.; Pannell, L. K. Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing progression of breast cancer J. Proteome Res. 2007, 6, 2993-3002
16. Kulasingam, V.; Diamandis, E. P. Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets Mol. Cell. Proteomics 2007, 6, 1997-2011
17. Wu, C. C.; Chen, H. C.; Chen, S. J.; Liu, H. P.; Hsieh, Y. Y.; Yu, C. J.; Tang, R.; Hsieh, L. L.; Yu, J. S.; Chang, Y. S. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes Proteomics 2008, 8, 316-332
18. Xue, H.; Lu, B.; Zhang, J.; Wu, M.; Huang, Q.; Wu, Q.; Sheng, H.; Wu, D.; Hu, J.; Lai, M. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach J. Proteome Res. 2010, 9, 545-555
19. Nickel, W. The mystery of nonclassical protein secretion: A current view on cargo proteins and potential export routes Eur. J. Biochem. 2003, 270, 2109-2119
20. Bendtsen, J. D.; Jensen, L. J.; Blom, N.; Von Heijne, G.; Brunak, S. Feature-based prediction of non-classical and leaderless protein secretion Protein Eng., Des. Sel. 2004, 17, 349-56
21. Mathivanan, S.; Simpson, R. J. ExoCarta: A compendium of exosomal proteins and RNA Proteomics 2009, 9, 4997-5000
22. Bhatia, V. N.; Perlman, D. H.; Costello, C. E.; McComb, M. E. Software tool for researching annotations of proteins: Open-source protein annotation software with data visualization Anal. Chem. 2009, 81, 9819-9823
23. Songsrirote, K.; Li, Z.; Ashford, D.; Bateman, A.; Thomas-Oates, J. Development and application of mass spectrometric methods for the analysis of progranulin N-glycosylation J. Proteomics 2010, 73, 1479-1490
24. Díaz-Cueto, L.; Stein, P.; Jacobs, A.; Schultz, R. M.; Gerton, G. L. Modulation of mouse preimplantation embryo development by acrogranin (epithelin/granulin precursor) Dev. Biol. 2000, 217, 406-418
25. He, Z.; Ong, C. H.; Halper, J.; Bateman, A. Progranulin is a mediator of the wound response Nat. Med. 2003, 9, 225-229
26. Cheung, S. T.; Wong, S. Y.; Leung, K. L.; Chen, X.; So, S.; Ng, I. O.; Fan, S. T. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma Clin. Cancer Res. 2004, 10, 7629-7636
27. Monami, G.; Emiliozzi, V.; Bitto, A.; Lovat, F.; Xu, S. Q.; Goldoni, S.; Fassan, M.; Serrero, G.; Gomella, L. G.; Baffa, R.; Iozzo, R. V.; Morrione, A. Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth Am. J. Pathol. 2006, 174, 1037-47
28. Monami, G.; Gonzalez, E. M.; Hellman, M.; Gomella, L. G.; Baffa, R.; Iozzo, R. V.; Morrione, A. Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex Cancer Res. 2006, 66, 7103-10
29. Miyanishi, M.; Mandai, M.; Matsumura, N.; Yamaguchi, K.; Hamanishi, J.; Higuchi, T.; Takakura, K.; Fujii, S. Immortalized ovarian surface epithelial cells acquire tumorigenicity by acrogranin gene overexpression Oncol. Rep. 2007, 17, 329-333
30. Pizarro, G. O.; Zhou, X. C.; Koch, A.; Gharib, M.; Raval, S.; Bible, K.; Jones, M. B. Prosurvival function of the granulin-epithelin precursor is important in tumor progression and chemoresponse Int. J. Cancer 2007, 120, 2339-2343
31. Lovat, F.; Bitto, A.; Xu, S.; Fassan, M.; Goldoni, S.; Metalli, D.; Wubah, V.; McCue, P.; Serrero, G.; Gomella, L. G.; Baffa, R.; Iozzo, R. V.; Morrione, A. Proepithelin is an autocrine growth factor for bladder cancer Carcinogenesis 2007, 30, 861-868
32. Davidson, B.; Alejandro, E.; Flørenes, V. A.; Goderstad, J.; Risberg, B.; Kristensen, G. B.; Trope, C. G.; Kohn, E. C. Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma Cancer 2004, 100, 2139-2147
33. Cuevas-Antonio, R.; Cancino, C.; Arechavaleta-Velasco, F.; Andrade, A.; Barron, L.; Estrada, I.; Fernandez, R. L.; Olguiin, V.; Ruiz, S.; Imani, F.; Zeferino-Toquero, M.; Ullia-Aguirre, A.; Gerton, G. L.; Diaz-Cueto, L. Expression of progranulin (acrogranin/PCDGF/granulin-gpithelin precursor) in benign and malignant ovarian tumors and activation of MAPK signaling in ovarian cancer cell line Cancer Investigation 2010, 28, 452-458
34. Han, J. J.; Yu, M.; Houston, N.; Steinberg, S. M.; Kohn, E. C. Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers Gynecol. Oncol. 2011, 120, 5-10
35. Pan, C.; Kinch, M. S.; Kiener, P. A.; Langermann, S.; Serrero, G.; Sun, L.; Corvera, J.; Sweeney, C. J.; Li, L.; Zhang, S.; Baldridge, L. A.; Jones, T. D.; Koch, M. O.; Ulbright, T. M.; Eble, J. N.; Cheng, L. PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma Clin. Cancer Res. 2004, 10, 1333-1337
36. Serrero, G.; Ioffe, O. B. Expression of PC-cell-derived growth factor in benign and malignant human breast epithelium Hum. Pathol. 2003, 34, 1148-1154